Offstream
news

Pfizer and the Medicines Patent Pool sign a global licensing agreement that will allow Pfizer's experimental COVID-19 oral drug Paxlovid to be manufactured under a royalty-free license in 95 low and middle-income countries.
2021-11-16

A late-stage trial of the oral drug Paxlovid conducted by Pfizer shows an 89% reduction in hospitalizations and deaths.
2021-11-5

Rady Children's Hospital in San Diego administers the first vaccines to children between the ages of 5 and 11 years old after Pfizer's COVID-19 vaccine was approved for use in children by the U.S. CDC.
2021-11-3

South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine.
2021-08-13

Kosovo signs an agreement with Pfizer to buy 1.2 million doses of the Pfizer–BioNTech vaccine, with the vaccine rollout expected to begin on June 15.
2021-05-28

U.S. President Joe Biden announces that his administration has finalized a deal purchasing a total of 200 million vaccine doses from Moderna and Pfizer.
2021-02-11

Chile begins its vaccination campaign against COVID-19 after the arrival of 10,000 doses of Pfizer-BioNTech vaccine to the country.
2020-12-24

Two health care workers at Bartlett Regional Hospital in Juneau have a severe allergic reaction after being administered Tozinameran, the Pfizer-BioNTech vaccine for COVID-19. Both healthcare workers are expected to recover.
2020-12-16

Pfizer and BioNTech say that their potential vaccine is 90% effective at preventing COVID-19 infections.
2020-11-9